The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells

NCT06993766 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Relapsed B-ALL
CAR T-cells
CD19-directed CAR T-cell Therapy

Sponsor

King Faisal Specialist Hospital & Research Center